Vocal Biomarkers Market By Therapeutic Applications (Psychiatric Disorders, Parkinson’s Disease, Cognitive Impairment, Brain Trauma Injury, Respiratory Disorders, Cardiovascular Disorders and Others), By End user (Hospitals, Health Insurers, Academic Institutes, and Government Organizations) and By Region - Trends, Analysis and Forecast till 2034

Size of the vocal biomarkers market was estimated at USD 2.6 billion in 2024 and is projected to increase at a CAGR of 15.10% to reach USD 9.4 billion by 2034.

Anxiety disorders, attention deficit disorder, depression, and other mental health conditions have all been diagnosed using sound vibrations as biomarkers. Vocal biomarkers, which aid in the detection, recording, and analysis of various disease types based on sound characteristics, have emerged as a result of recent advancements in research on these aspects of an individual's sound. Vocal biomarkers have the advantage of being able to diagnose patients who are located far away. For telemedicine and related healthcare delivery, this makes it the perfect diagnostic tool. Vocal biomarkers would also be expensive. Compared to traditional biomarkers, which are expensive and place a heavy healthcare burden on governments and insurance payer organizations, this noninvasive method is effective. Furthermore, these biomarkers would enable self-medication and self-diagnosis, which would greatly raise the need for vocal biomarkers in the near future.